Abstract
Normally, antibodies against influenza A have been prepared from viable virus or an engineered strain in certain hosts or cultured media. Two factors concerning antibody production are obvious. The obtaining antibody that is a kind of biomolecule has to be handled carefully, e.g., to be kept in a refrigerator. Furthermore, when the virus strain is highly pathogenic, such as H5N1, antibody production has to be done carefully in a high-level biosafety lab. Here, we show how to produce an antibody against H5N1 from a polymeric material using inactivated virus which can be conducted in a low-level biosafety lab. The process is based on imprinting the whole virus on a polymer surface to form molecularly imprinted polymers (MIPs). The MIPs show some properties of H5N1 antibody as they recognize H5N1 and have some important antibody activity. The H5N1 MIPs are not to be considered biomaterial, so they can be stored at room temperature and thus do not need any special care.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Edwin DK (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12(1):9. doi:10.3201/eid1201.051254
Beveridge WI (1991) The chronicle of influenza epidemics. Hist Philos Life Sci 13(2):223–234
Jeffery T, David MM (2006) 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 12(1):15. doi:10.3201/eid1201.050979
Taubenberger JK (2006) The origin and virulence of the 1918 “Spanish” influenza virus. Proc Am Philos Soc 150(1):86–112
Watanabe T, Kawaoka Y (2011) Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog 7(1):e1001218. doi:10.1371/journal.ppat.1001218
Kim H-R, Lee Y-J, Park C-K, Oem J-K, Lee OS, Kang H-M, Choi J-G, Bae Y-C (2012) Highly pathogenic avian influenza (H5N1) outbreaks in wild birds and poultry, South Korea. Emerg Infect Dis 18(3):480–483. doi:10.3201/eid1803.111490
Eagles D, Siregar ES, Dung DH, Weaver J, Wong F, Daniels P (2009) H5N1 highly pathogenic avian influenza in Southeast Asia. Rev Sci Tech 28(1):341–348
Gutiérrez RA, Naughtin MJ, Horm SV, San S, Buchy P (2009) A(H5N1) virus evolution in South East Asia. Viruses 1(3):335–361. doi:10.3390/v1030335
Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R, Huai Y, Dong J, Bao C, Wen L, Wang H, Yang P, Zhao W, Dong L, Zhou M, Liao Q, Yang H, Wang M, Lu X, Shi Z, Wang W, Gu L, Zhu F, Li Q, Yin W, Yang W, Li D, Uyeki TM, Wang Y (2008) Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371(9622):1427–1434. doi:10.1016/S0140-6736(08)60493-6
Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S (2005) Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352(4):333–340. doi:10.1056/NEJMoa044021
Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y (2008) Human infection with highly pathogenic H5N1 influenza virus. Lancet 371(9622):1464–1475. doi:10.1016/S0140-6736(08)60627-3
Baz M, Luke CJ, Cheng X, Jin H, Subbarao K (2013) H5N1 vaccines in humans. Virus Res 178(1):78–98. doi:10.1016/j.virusres.2013.05.006
Kang S-M, Yoo D-G, Lipatov AS, Song J-M, Davis CT, Quan F-S, Chen L-M, Donis RO, Compans RW (2009) Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One 4(3):e4667. doi:10.1371/journal.pone.0004667
Wangchareansak T, Thitithanyanont A, Chuakheaw D, Gleeson MP, Lieberzeit PA, Sangma C (2013) Influenza A virus molecularly imprinted polymers and their application in virus sub-type classification. J Mater Chem B 1(16):2190–2197. doi:10.1039/C3TB00027C
Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, Yongvanitchit K, Kum-Arb U, Kanchongkittiphon W, Utaisincharoen P, Sirisinha S, Puthavathana P, Fukuda MM, Pichyangkul S (2007) High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-α and TLR ligands. J Immunol 179(8):5220–5227. doi:10.4049/jimmunol.179.8.5220
Eisfeld AJ, Neumann G, Kawaoka Y (2014) Influenza A virus isolation, culture and identification. Nat Protoc 9(11):2663–2681. doi:10.1038/nprot.2014.180
Wangchareansak T, Thitithanyanont A, Chuakheaw D, Gleeson MP, Lieberzeit PA, Sangma C (2014) A novel approach to identify molecular binding to the influenza virus H5N1: screening using molecularly imprinted polymers (MIPs). Med Chem Commun 5(5):617–621. doi:10.1039/C3MD00272A
Acknowledgments
This work has been supported by Royal Golden Jubilee Ph.D. Program (RGJ), Thailand Research Fund (TRF), Kasetsart University Research and Development Institute (KURDI), the National Research University Project of Thailand (NRU), and ASEAN-European Academic University Network (ASEA-UNINET).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Sangma, C., Lieberzeit, P.A., Sukjee, W. (2017). H5N1 Virus Plastic Antibody Based on Molecularly Imprinted Polymers. In: Tiller, T. (eds) Synthetic Antibodies. Methods in Molecular Biology, vol 1575. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6857-2_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6857-2_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6855-8
Online ISBN: 978-1-4939-6857-2
eBook Packages: Springer Protocols